Cite Filings / WHWK / 0000902664-21-004068
Feed Companies Filings Check
Sign in
SC 13D/A

Beneficial Ownership Report

Whitehawk Therapeutics, Inc. · Filed 2021-08-30 · Acc 0000902664-21-004068

Documents 1

  • SC 13D/A Beneficial Ownership Report , p21-2018sc13da.htm

Around this filing

  • 2021-09-03 SC 13D/A Beneficial Ownership Report
  • 2021-08-30 4 Director acquired 1,911,752 shares (grant or award)
  • 2021-08-30 3 Initial Statement of Ownership
  • 2021-08-30 SC 13D/A Beneficial Ownership Report
  • 2021-08-30 4 Director bought 259,998 shares at $13.08 ($3,399,994)
  • 2021-08-30 4 Director bought 1,529,402 shares at $13.08 ($19,999,990)
  • 2020-11-23 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Dellora Investments LP 5.6%
  2. 2026-11-16 SCHEDULE 13G/A · ABG Global Life Science Capital Partners V GP Limited 7.8%
  3. 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 6.19%
Loading p21-2018sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…